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and Bodil S Rasmussen2Abstract
Background: It can be difficult to perform CT guided biopsy of small pulmonary nodules especially if the position
is behind a costa or close to the diaphragm and respiratory movements may hamper the procedure. During apneic
oxygenation with a pulmonary standstill these movements can be hindered.
Methods: Six patients with decreased lung function and suspicious lung nodules are presented. Under general
anesthesia including a muscle relaxant and a cuffed tube in the trachea CT guided biopsy was prepared. Just
before the biopsy the ventilation mode was switched to a continuous positive airway pressure of 5–10 cm H2O,
maintaining 100% oxygen delivery without ventilation. If the position of the lung nodule was inconvenient for
biopsy the pressure was increased to up to 17 cm H2O to expand the lungs to a better biopsy position. After
retrieving the biopsy controlled ventilation was re-established and a finishing control CT-scan was performed. Blood
gas analyses were performed with few minutes interval.
Results: All biopsies were diagnostic. All patients survived the procedure with no major complications, but 3
patients developed pneumothorax. The length of apneic oxygenation was median 10 minutes (8–10 minutes). No
major changes in vital parameters were observed, and in all patients the peripheral oxygen saturation was 100%
throughout the procedure. The arterial oxygen tension rose to very high values and the lowest pH was 7.18.
Conclusions: It is possible to perform lung biopsies in selected patients with decreased lung function during
apneic oxygenation in at least 10 minutes in a safe way.Background
In lung cancer establishment of an early diagnosis is im-
portant, even if the patient is not suitable for treatment
with surgical lung resection. In many cases radiotherapy
is a valuable method in the treatment of lung cancer,
leading to better survival rates and better quality of life
[1]. In other cases, treatment with chemotherapy, and in
some cases with targeted chemotherapy such as Gefitinib,
is beneficial [2,3]. However, before the initiation of treat-
ment, it is mandatory that a diagnosis is established. Even
if new treatment is successful from the start with reduc-
tion in tumour size, the tumours may undergo transform-
ation during therapy, which can be a good reason for* Correspondence: benedict@dadlnet.dk
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article, unless otherwise stated.performing a re-biopsy. If the tumours have transformed
and acquired resistance to the initial treatment, it is pos-
sible to adjust the treatment in time, by means of the re-
sult of a re-biopsy [4].
A CT- guided needle biopsy is a valuable diagnostic tool
for the diagnosis of pulmonary nodules and has only few
serious complications, except for pneumothorax, which is
seen in 1/3 of the patients undergoing this procedure [5].
Although small tumours have the best prognoses, these
are more difficult targets to hit with a CT-guided trans-
thoracic needle biopsy, the sensitivity of the procedure
thereby being lower. The position of a suspicious pulmon-
ary nodule, e.g. behind a rib, or close to the diaphragm
can make it difficult to perform a biopsy, and respiratory
movements may hamper it further.
For this, and similar procedures demanding a pulmon-
ary standstill, several alternatives to breathing have been
suggested over the years, including passive oxygenation
via a catheter inserted into the lungs [6]. However, thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Kjaergaard et al. Multidisciplinary Respiratory Medicine 2013, 8:73 Page 2 of 5
http://www.mrmjournal.com/content/8/1/73accumulation of carbon dioxide and lung collapse have
been limiting factors. A well-known method for ventila-
tion of the apneic lungs is jet ventilation [7]. This may
also be an option when performing a biopsy of hard-to-
reach tissue, however, during jet ventilation you cannot
change position of a nodule by expanding the lungs.
Studies of both humans and animals have shown that
it is possible to stop ventilation for a prolonged period
of time without oxygenation problems, if the lungs are
subjected to a constant supply of oxygen, and a continu-
ous positive airway pressure (CPAP) between 5 and
20 cm H2O, to keep the lungs open to avoid shunting of
deoxygenated blood through the lungs [8-11]. This will
lead to a carbon dioxide accumulation, and a corre-
sponding fall in pH to about 7.0 after 30 minutes. It is
very important to use 100% pure oxygen, since nitrogen
in the gas supply will lead to alveolar nitrogen accumu-
lation with a sudden decrease in blood oxygen saturation
[12-14]. This technique is called apneic oxygenation.
In this study we present our first experiences with ap-
neic oxygenation in patients where normal CT-guided
needle lung biopsies failed for different reasons.
Methods and materials
The local Institutional Review Board was consulted and
the methods were approved for such pilot study aimed
to evaluate if CT-guided lung biopsy is possible during
apneic oxygenation. Hereby we present our first 6 con-
secutive patients. The median age of the patients was 62
years (50–77 years), all patients had decreased lung func-
tion with a FEV1 median of 44% (32–63%). For various
reasons none of the patients were candidates for lung sur-
gery. Three of the patients had previously suffered from
cancer. All patients went through our standard diagnostic
procedures for patients with suspicious symptoms of lung
cancer, including a PET-CT scan, bronchoscopy, endo-
bronchial ultrasound-guided mediastinal lymph node bi-
opsy. The Department of Anaesthesiology and IntensiveTable 1 Patients’ characteristics
Age FEV1 Nodule size Location of nod
Patient 1 69 years 35% 20 mm Segment 3
Patient 2 50 years 32% 10 mm Segment 4
Very central
Patient 3 77 years 34% 24 mm Segment 6
Pleura near
Patient 4 77 years 57% 25 mm Segment 8
Patient 5 52 years 63% 25 mm Segment 9
Diaphragm near
Patient 6 54 years 53% 10 mm Segment 10
Pleura nearCare, Aalborg University Hospital, performs approxi-
mately 300 CT-guided needle lung biopsies per year, and
the 6 patients included in our study have been referred to
lung biopsies and included in our study within 1 year, they
represent 2% of the approximately 300 patients, that are
referred to diagnostic lung biopsies per year.
During the previous attempts to perform lung biopsies,
three out of five patients developed a substantial pneumo-
thorax, and were treated with a chest tube. Patients’ char-
acteristics are shown in Table 1.The reason for choosing apneic biopsy
Patient 1: This patient developed pneumothorax during
the procedure, and was in a critical condition until a
chest tube was inserted. Later we realized that the biopsy
was inconclusive.
Patient 2: This patient had a very low oxygen diffusion
coefficient of 15%, and an attenuated lung structure. To
minimize the risk of getting an inconclusive lung biopsy the
patient was a preselected candidate to an apneic biopsy.
Patient 3: This patient’s biopsy from a nodule behind a
rib turned out to be inconclusive.
Patient 4: This patient’s biopsy turned out to be incon-
clusive, and because of dyspnoea the first attempt was
abandoned.
Patient 5: This patient’s biopsy turned out to be be-
nign, however on a CT scan it appeared very suspicious
and because of the nodules’ location close to the dia-
phragm, it was difficult to achieve a representative biopsy,
and therefore it was repeated during apneic oxygenation.
Patient 6: This patient experienced severe coughing
and bleeding from the airways during the first unsuc-
cessful attempt to perform a biopsy.Anaesthesiology procedure
Prior to lung biopsies in apneic oxygenation all patients




17 cm H2O Yes Malign
10 cm H2O Yes Malign
10 cm H2O No Malign
6 cm H2O Yes Malign
8 cmH2O No Benign
10 cm H2O No Malign
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A cuffed endotracheal tube was inserted (Potex, Smiths
Medical, Watford, United Kingdom) and connected to a
Dräger Primus® ventilator (Dräger Medical GmbH, Lübeck,
Germany). Normoventilation or slight hyperventilation
was obtained using a volume controlled ventilation mode
with tidal volumes 6–8 mL/kg, respiratory frequency 12-
14/minute, and positive end expiratory pressure (PEEP),
5 cm H2O.
Arterial blood samples were drawn for analysis (ABL
800, Radiometer, Copenhagen, Denmark) at baseline,
within 1 minute after start of apneic oxygenation and
every 5 to 10 minutes during, and after the procedure,
until the values were normalized. The patient was placed
in the CT scanner and after correct positioning and prepar-
ation for biopsy, rucoronium 0.6 mg* kg-1 (a muscle relax-
ing medication) was given to avoid any movements due to
carbon dioxide accumulation. A train-of-four (TOF) moni-
tor (TOF-watch®, Organon Ltd, Dublin Ireland) was used
to monitor the neuromuscular block. After 2 minutes of
pre-oxygenation with 100% oxygen, the ventilation mode
was switched to a continuous positive airway pressure
(CPAP) of 5–10 cm H2O, maintaining 100% oxygen deliv-
ery without ventilation. The patient was continuously
observed with pulse oxymetry (Dräger Medical GmbH,
Lübeck, Germany). If the position of a lung nodule pre-
cluded a biopsy, the pressure was increased according to
our schedule, not higher than 20 cm H2O. The highest
value in this small study was 17 cm H2O, which expanded
the lung to a much better biopsy position. After retrieving
the biopsy, controlled ventilation was re-established and a
concluding CT-scan was performed to reveal a possible
pneumothorax. In case of a clinical symptomatic pneumo-
thorax a chest tube Charrière 18 was inserted. Ventilation
was continued until the patient was at his/her own condi-
tions and was normoventilated, or had a satisfactory elim-
ination of carbon dioxide. The patient was transferred to
the recovery room and after additional 2–3 hours to the
medical ward.
The procedure could only be performed in our largest
CT rooms, which normally are used for trauma patients,
since we needed space for a bed, a ventilator, equipment
for pleural drainage and all technical installations for the
ventilator and the monitors.
Radiologic procedure
The CT-guided needle lung biopsies were performed by
an experienced radiologist. CT scanners of various types
were used, e.g. GE Lightspeed® Pro 32 slices, GE Light-
speed® VCT and GE Discovery 750 HD both 64 slices
(GE, Milwaukee, USA) and Siemens Somatom 10 (Siemens
Medical Systems, Erlangen, Germany). The patient was
anaesthetized and positioned in the CT scanner. A CTscout view in 2 plans was performed by a preliminary CT
scan with 3 mm axial slices of the lung section, containing
the lesion of interest. The access point was planned and
the distance to the target was measured taking into consid-
eration the topography of the lesion in relation to the
surrounding structures. The entry site on the skin was
marked with a pen guided by the laser lightning of the CT
scanner and followed by antiseptic procedure. No local an-
aesthesia was used. A small incision was made in the skin,
and a 19G coaxial biopsy needle (BARD Truguide Coaxial
Biopsy Needle) was placed in the thoracic wall nearby the
pleura while checking the progress of the needle by means
of small CT scans, 11–13 slices in a CT-biopsy mode. The
patient was switched from ventilation to apneic oxygen-
ation and the coaxial needle was placed in the periphery of
the lesion, again checking the progress of the needle by
means of CT scans. 3 core biopsies were achieved with a
biopsy needle 20 G (BARD Monopty Core Biopsy Instru-
ment), and were immediately placed on paper and put in
containers with formalin. After that a fine needle aspiration
biopsy was performed with a 22 G needle (“Franseen” Bi-
opsy Needle, Angiotech) attached to a 20 ml syringe placed
in a handle. Aspirates were smeared on glass slides. Con-
trolled ventilation was re-established.Statistics
All values are medians with ranges.Results
All biopsies were diagnostic. The biopsies revealed that 5
out of 6 patients had malignant diagnoses, and the last pa-
tient had sarcoidosis. All 6 patients survived the procedure
with no major complications, however 3 patients devel-
oped a clinical symptomatic pneumothorax and needed
pleural drainage for median 1.5 days (1–9 days). In this
small study it was not possible to identify any connection
between the CPAP values during apnea and pneumo-
thorax. The length of apneic oxygenation was median
10 minutes (8–10 minutes). During the apneic period no
major changes in blood pressure or pulse rate were
observed, and in all 6 patients the peripheral oxygen satur-
ation was 100% throughout the whole procedure. The ar-
terial oxygen tension rose to very high values, maybe also
due to pre-oxygenation and was 55,4 (22,3-83,6) kPa
within the first minutes after start of the apneic oxygen-
ation, and at the end of the apneic period the values were
57,3 (18,1-77) kPa. None of the patients experienced a ser-
ious drop in blood pH due to carbon dioxide accumula-
tion (Figure 1).
Appropriate treatment for the underlying diseases was
instituted in all patients afterwards.
The whole procedure, from initiation of anaesthetization


































































Figure 1 Arterial blood examination during the apneic and recovery period.
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mately 1 ½ hour per patient.Discussion and conclusions
In our opinion, apneic oxygenation is an option for im-
proving the accuracy of lung biopsies, in particular in
patients with small nodules, and in nodules with posi-
tions hard to reach, despite the fact that both fluoros-
copy and a CT-guided biopsy mode are performed by an
experienced radiologist. By changing the airway pressure
to a level between 6 and 17 cm H2O, it was even pos-
sible to change position of a nodule to facilitate the pro-
cedure of biopsy. In this small study it was not possible
to investigate the effect of CPAP on pneumothorax. Of
course, the procedure demands general anaesthesia and
mechanical ventilation for some minutes afterwards to
normalize carbon dioxide level, but we still find this pro-
cedure more favourable than repetitive biopsy proce-
dures, or even an open surgical procedure to establish
the correct diagnosis. We also consider the procedure
safe as long as the patient is tightly monitored. The ap-
neic oxygenation can very easily be switched to con-
trolled ventilation if indicated. Even though the patient
accumulates carbon dioxide and develops acidosis dur-
ing apneic oxygenation, this is not as dangerous, as in
the critical ill lung patient, since arterial oxygen tension
is very high, and since hypercapnia will be reverted
immediately after the procedure. We do not know how
much pre-oxygenation contributed to the very high values
of PaO2 measured already within the first minute of
apnea, but the values did not fall during the apneic period.
However, there are some clear contraindications to hyper-
capnia such as sickle cell disease, increased intracranial
pressure and pulmonary hypertension. We do not knowhow much the risk of pneumothorax is altered during
the procedure. During apnea the slightly elevated airway
pressure is at least partly transmitted to the pleural
cavity reducing the pressure difference compared to the
situation in a patient treated with a ventilator. But when
the apneic oxygenation is switched to the ventilator,
pneumothorax may develop and a preparedness for
chest drainage is necessary, especially because tension
pneumothorax is a risk after resumption of mechanical
ventilation. It is unclear if apneic oxygenation may in-
crease the risk of air embolism, but the airway pressure
during apnea is not as high as the peak pressure during
coughing. Air embolism happened in less than 1‰ of
conventional lung biopsies in 2 big series that included
more than 15,000 patients [5,15].
Optimizing the biopsy procedure includes the participa-
tion of a pathologist, who performs immediate preliminary
microscopy, insuring that the biopsy is representative. The
time spent in the CT room could be reduced, if we had a
room for inducing anaesthesiology adjacent to the CT
room at our disposal. There may also be possibilities in
stereotactic devices for CT-guided lung biopsy when the
patient does not move during the procedure.
Treatment with apneic oxygenation may even be use-
able for stereotactic radiotherapy and for radiofrequency
ablation for lung cancer.Consent
All patients included gave informed consent to participa-
tion to the study.
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